Dr. Endo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4245 Roosevelt way
Seattle, WA 98105Phone+1 206-598-4882
Summary
- Dr. Mayumi Endo, based in Seattle, WA, specializes in Endocrinology, with a focus on Parathyroid and Thyroid care. She completed fellowships in Endocrinology, Diabetes, and Metabolism at both Stanford Health Care-Sponsored Stanford University and the National Institutes of Health Clinical Center, after finishing her residency in Internal Medicine at Oregon Health & Science University. Currently, Dr. Endo serves as an Assistant Clinical Professor at UW Medicine/University of Washington Medical Center, a position she's held since 2020. She has past experience in the same position at Ohio State University Wexner Medical Center and The OSUCCC - James. Dr. Endo is experienced in fine needle aspiration and has contributed to a range of publications in the field of endocrinology.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2013
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2009 - 2012
- OtherClass of 2005
Certifications & Licensure
- WA State Medical License 2016 - 2026
- CA State Medical License 2014 - 2024
- OH State Medical License 2016 - 2021
- MD State Medical License 2012 - 2014
- OR State Medical License 2011 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Beyond malignancy risk stratification: FNAC report anticipates thyroid cancer staging. Insights from recent studies.Mario Rotondi, Mayumi Endo, Marsida Teliti, Anna Crescenzi, Irina Azaryan
The Journal of Clinical Endocrinology and Metabolism. 2024-10-01 - Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.Mayumi Endo, Jing Peng, Fadi A Nabhan, Pamela Brock, Irina Azaryan
The Journal of Clinical Endocrinology and Metabolism. 2024-08-13 - Histopathology of telomerase reverse transcriptase promoter () mutated indeterminate thyroid nodules.Jessica O Pinto, Masha J Livhits, Michael W Yeh, Atanas Kaykov, Joshua P Klopper
Journal of Clinical & Translational Endocrinology. 2024-03-01
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: